Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771505015 | Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3771506019 | Sodium benzoate and sodium phenylacetate only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Is a | Sodium benzoate- and sodium phenylacetate-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Is a | Sodium benzoate and sodium phenylacetate only product | true | Inferred relationship | Some | ||
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Has active ingredient | Sodium benzoate | true | Inferred relationship | Some | 2 | |
| Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Has active ingredient | Sodium phenylacetate | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection | Is a | True | Sodium benzoate and sodium phenylacetate only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR